Abstract:Introduction: For non-invasive intraductal papillary and mucinous neoplasm (IPMN) with limited extent, pancreaticoduodenectomy (PD) or distal pancreatectomy (DP) seem excessive due to the risk of pancreatic insufficiency. Enucleation (EN) or medial pancreatectomy (MP) are not commonly performed for IPMN. The aim of this study was to evaluate the feasibility and results of EN and MP for non-invasive IPMN. Patients and methods: Of 249 patients with IPMN, we attempted a limited resection in 50 (20%) EN (n=31) or MP (n=20) with routine intra-operative frozen section pathology. One attempted EN was converted to MP. Indications for surgery were pain/pancreatitis (44%), suspicion of main duct involvement (28%), mural nodules in branch duct (14%), branch duct>30 mm (8%) or suspicion of mucinous cystadenoma (6%). Follow-up clinical assessment and MRI were performed on a yearly basis. Results: Of the 31 attempted enucleations, 5 (13%) were immediately converted (4 PD, 1 MP) due to technical reasons (n=3) or due to findings on frozen section (n=2). At definitive pathological examination (accuracy of frozen sectioning=98%), branch ducts were involved by mild (n=21), moderate (n=7) or high grade dysplasia (n=2). One patient underwent a double EN. Of 20 attempted medial pancreatectomies, 8 (40%) required additional segmental resection due to significant IPMN lesions at pancreatic margins; 3 of the additional resection margins were tumor-free, and 5 were involved by IPMN (4 conversions to PD or DP, one contra-indication to PD). Overall, 49 pancreatic margins were analyzed by frozen sectioning with 98% accuracy. Resected specimens of 16 MP showed involvement by mild (n=7), moderate (n=7) or high grade dysplasia (n=2). There was no postoperative mortality. Median length of stay was 21 and 30 days respectively after EN and MP. Pancreatic fistula rate was 54% and 81% respectively after EN and MP. Three patients underwent early re-operation for hemorrhage. Overall median follow-up was 24 months (3-121). All patients are alive, 2 patients (5%) have presented with recurrent pain and 4 have developed tumor recurrence on imaging follow-up (4/33=12%). Two patients (5%) developed de novo diabetes (one after EN combined with DP) and a third patient developed worsening of pre-existing diabetes plus exocrine insufficiency. No patient had surgery for recurrence. Conclusions: EN and MP are feasible for non-invasive IPMN. Their significant early morbidity is counterbalanced by low rates of both long-term functional disorders and tumor recurrence.

Middle pancreatectomy: indications, short- and long-term operative outcomes

Expanding Laparoscopic Pancreaticoduodenectomy to Pancreatic-Head and Periampullary Malignancy: Major Findings Based on Systematic Review and Meta-Analysis

Minimally invasive pancreaticoduodenectomy for periampullary disease: a comprehensive review of literature and meta-analysis of outcomes compared with open surgery

The Short- and Long-Term Outcomes of Laparoscopic Pancreaticoduodenectomy Combining with Different Type of Mesentericoportal Vein Resection and Reconstruction for Pancreatic Head Adenocarcinoma: a Chinese Multicenter Retrospective Cohort Study

Evolution Of Laparoscopic Pancreatic Resections For Pancreatic And Periampullary Diseases: Perioperative Outcomes Of 605 Patients At A High-Volume Center

Middle-preserving pancreatectomy: report of two cases and review of the literature

Short- and Long-Term Outcomes of Laparoscopic Organ-Sparing Resection for Pancreatic Neuroendocrine Neoplasms

Patients get more long-term benefit from central pancreatectomy than distal resection: A meta-analysis

Middle Segmental Pancreatectomy: A Safe and Organ-Preserving Option for Benign and Low-Grade Malignant Lesions

Laparoscopic central pancreatectomy with pancreaticojejunostomy: preliminary experience with 8 cases.

Laparoscopic Spleen-Preserving Distal Pancreatectomy for Pancreatic Neoplasms: a Retrospective Study.

Clinically Application of Middle Segmental Pancreatectomy:Analysis of 40 Cases

Laparoscopicvsopen Distal Pancreatectomy for Solid Pseudopapillary Tumor of the Pancreas

Initial Experiences in Robot-Assisted Middle Pancreatectomy

Analysis of the clinical efficacy of laparoscopic middle pancreatectomy in the treatment of benign or low-grade malignant tumors of the pancreas

Prognostic impact of conservative surgery for pancreatic IPMNs

[Limited pancreatic resections for intraductal papillary mucinous neoplasm]

Efficacy of Pancreatic Duct Stenting Prior to Laparoscopic Pancreatic Tumor Enucleation

Robot-assisted laparoscopic versus open middle pancreatectomy: short-term results of a randomized controlled trial

IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection

Laparoscopic Versus Open Pancreatic Resection for Ductal Adenocarcinoma: Separate Propensity Score Matching Analyses of Distal Pancreatectomy and Pancreaticoduodenectomy.